
Thirumalai Chemicals Limited
NSE:TIRUMALCHM.NS
237.34 (INR) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 20,715.1 | 21,322.4 | 19,969.8 | 10,849.1 | 10,824.2 | 12,575.4 | 13,105.9 | 10,327.578 | 9,441.721 | 10,722.586 | 12,762.383 | 13,714.995 | 10,515.822 | 7,685.288 | 6,256.793 | 4,702.219 | 5,879.79 |
Cost of Revenue
| 16,849.9 | 15,311.7 | 12,319.2 | 6,692 | 8,007.5 | 8,522.6 | 8,138.5 | 6,957.032 | 6,634.203 | 8,505.343 | 10,247.049 | 10,564.845 | 8,335.05 | 6,088.52 | 4,811.453 | 4,074.774 | 4,300.879 |
Gross Profit
| 3,865.2 | 6,010.7 | 7,650.6 | 4,157.1 | 2,816.7 | 4,052.8 | 4,967.4 | 3,370.546 | 2,807.518 | 2,217.243 | 2,515.334 | 3,150.15 | 2,180.772 | 1,596.768 | 1,445.341 | 627.444 | 1,578.912 |
Gross Profit Ratio
| 0.187 | 0.282 | 0.383 | 0.383 | 0.26 | 0.322 | 0.379 | 0.326 | 0.297 | 0.207 | 0.197 | 0.23 | 0.207 | 0.208 | 0.231 | 0.133 | 0.269 |
Reseach & Development Expenses
| 24.7 | 25.3 | 26.4 | 29 | 32.5 | 33.6 | 30.5 | 27.106 | 18.312 | 12.407 | 11.607 | 17.381 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 171.9 | 194.6 | 112.3 | 95 | 78.6 | 83.3 | 82.5 | 61.117 | 59.724 | 0 | 25.729 | 53.155 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 1,033.8 | 994.8 | 1,187.1 | 566.3 | 508.8 | 518.5 | 590.3 | 461.767 | 28.874 | 0 | 432.949 | 622.8 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 1,205.7 | 1,189.4 | 1,299.4 | 661.3 | 587.4 | 601.8 | 672.8 | 522.885 | 88.598 | 365.828 | 892.17 | 1,056.553 | 0 | 0 | 0 | 0 | 0 |
Other Expenses
| 2,696.8 | 301.5 | 11.2 | 10.6 | 17.2 | 12.2 | 10.2 | 3.968 | 4.108 | 4.233 | 4.029 | 4.188 | 3.944 | 3.023 | 2.015 | 1.938 | 1.988 |
Operating Expenses
| 3,865.2 | 4,705.6 | 3,777.1 | 2,441.6 | 2,419.3 | 2,339.3 | 2,308.4 | 2,111.027 | 2,000.464 | 1,984.751 | 1,918.686 | 2,014.717 | 1,662.136 | 1,215.982 | 874.376 | 1,184.88 | 987.638 |
Operating Income
| -62 | 1,312.7 | 3,876.5 | 1,719.3 | 395.1 | 1,713.5 | 2,659 | 1,259.52 | 548.356 | -68.029 | 148.721 | 644.635 | 20.282 | 248.276 | 380.258 | -698.74 | 467.823 |
Operating Income Ratio
| -0.003 | 0.062 | 0.194 | 0.158 | 0.037 | 0.136 | 0.203 | 0.122 | 0.058 | -0.006 | 0.012 | 0.047 | 0.002 | 0.032 | 0.061 | -0.149 | 0.08 |
Total Other Income Expenses Net
| -283.5 | -44 | -148.6 | -168.3 | -15.8 | -24.9 | -129 | -155 | -244.847 | -383.297 | -755.336 | -498.515 | -394.779 | -180.138 | 0 | 0 | 0 |
Income Before Tax
| -345.5 | 1,294.1 | 3,753.7 | 1,571.3 | 381.6 | 1,688.6 | 2,530 | 1,092.073 | 548.356 | -68.029 | 148.721 | 644.635 | 20.282 | 248.276 | 380.258 | -698.74 | 467.823 |
Income Before Tax Ratio
| -0.017 | 0.061 | 0.188 | 0.145 | 0.035 | 0.134 | 0.193 | 0.106 | 0.058 | -0.006 | 0.012 | 0.047 | 0.002 | 0.032 | 0.061 | -0.149 | 0.08 |
Income Tax Expense
| 42.4 | 395.8 | 941.4 | 394.4 | 149.9 | 552.9 | 825.6 | 386.625 | 226.836 | 69.218 | 30.052 | 181.839 | 11.081 | 78.092 | 121.368 | -239.298 | 201.454 |
Net Income
| -387.9 | 898.3 | 2,812.3 | 1,176.9 | 231.7 | 1,135.7 | 1,704.4 | 705.448 | 321.52 | -137.247 | 118.668 | 438.091 | 9.182 | 179.446 | 258.615 | -460.009 | 266.706 |
Net Income Ratio
| -0.019 | 0.042 | 0.141 | 0.108 | 0.021 | 0.09 | 0.13 | 0.068 | 0.034 | -0.013 | 0.009 | 0.032 | 0.001 | 0.023 | 0.041 | -0.098 | 0.045 |
EPS
| -3.79 | 8.77 | 27.47 | 11.49 | 2.26 | 11.09 | 16.65 | 6.9 | 3.14 | -1.34 | 1.16 | 4.28 | 0.089 | 1.75 | 2.53 | -4.49 | 2.61 |
EPS Diluted
| -3.79 | 8.77 | 27.47 | 11.49 | 2.26 | 11.09 | 16.65 | 6.9 | 3.14 | -1.34 | 1.16 | 4.28 | 0.089 | 1.75 | 2.53 | -4.49 | 2.61 |
EBITDA
| 645.4 | 2,163.4 | 4,523.7 | 2,275.6 | 990.4 | 2,173.8 | 2,963.8 | 1,610.3 | 964.816 | 535.739 | 841.141 | 1,179.573 | 628.686 | 534.579 | 703.281 | -435.169 | 717.527 |
EBITDA Ratio
| 0.031 | 0.101 | 0.227 | 0.21 | 0.091 | 0.173 | 0.226 | 0.156 | 0.102 | 0.05 | 0.066 | 0.086 | 0.06 | 0.07 | 0.112 | -0.093 | 0.122 |